Combination Therapy for Myelomatosis

Plasma Cell Myelomatosis

Total body irradiation for myelomatosis.

In the first myeloma trial of the M.R.C. working party on leukaemia in adults the deaths that have occurred can be attributed to unrelated diseases (5%h-for example, cosonary thrombosis, etc.); causes indirectly telated to the tumour (80,for example, pneumonia due to the immune paresis); no obvious response of the tumour to treatment (27/); and finally relapse of the tumour after an initial res...

Combination therapy for onychomycosis.

Combination therapy is one way of improving the cure rate of onychomycosis. The LION Study examined the efficacies of terbinafine and itraconazole. The Icelandic cohort of the study reported that after 5 years only 46% of the terbinafine-treated patients and 13% of the itraconazole-treated patients were still disease-free, suggesting that relapses and reinfections were common in the long term t...

Combination therapy for hypertension.

Hypertension affects more than one tenth of the adult population in Hong Kong. In fact, using the latest recommended cut-off points for systolic blood pressure of 140 mm Hg and diastolic blood pressure of 90 mm Hg, the prevalence of hypertension in Hong Kong adults is close to 20%. The apparent increase in the prevalence of hypertension in recent years is largely due to increased recognition of...

Combination therapy for dyslipidemia.

In the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) guidelines, the emphasis of lipid-lowering therapy is placed on reaching target plasma low-density lipoprotein cholesterol (LDL-C) levels in order to reduce the risk for coronary heart disease (CHD). Although therapeutic lifestyle changes can have a positive effect on LDL-C levels, the ATP III recognizes th...